Connect your AI

Axogen AXGN Investing Cash Flow

Investing Cash Flow at other companies

Baxter InternationalBAX

-$133M-104%

StrykerSYK

-$185M+95.5%

LeMaitre VascularLMAT

-$13.12M-204%

MedtronicMDT

-$917M-87.1%

Other financials

Income statement

Revenue$61.5M+26.6%

Gross profit$46.2M+32.2%

Operating income-$2.8M-70.5%

Net income-$19.6M-411%

EPS (diluted)-$0.38-375%

Balance sheet

Cash & equivalents$84.7M+251%

Total debt$20.6M-69.8%

Total equity$244.8M+132%

Total assets$289.5M+47.6%

Cash flow

Operating cash flow$1.6M+112%

CapEx$2.8M+989%

Free cash flow-$1.2M+90.9%

Valuation

Market cap$2.26B+110%

Profitability

Gross margin75%+0.8pp

Operating margin-3.8%—

Net margin-13.2%-22.8pp

FCF margin-12.9%-3.8pp

Returns & leverage

Return on equity-18%-70.5pp

Debt / equity0.1×-0.6×

Current ratio7.1×+2.8×

Where this comes from

Reported directly by Axogen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Axogen's investing cash flow?: Axogen (AXGN) reported investing cash flow of -$15.96M in Q1 2026.
How has Axogen's investing cash flow changed year-over-year?: Axogen's investing cash flow decreased by 1292.2% year-over-year, from $1.34M to -$15.96M.
What is the long-term trend for Axogen's investing cash flow?: Over 2 years (2021 to 2024), Axogen's investing cash flow has grown at a -34.0% compound annual growth rate (CAGR), from -$23.65M to -$10.3M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.